US FTC Removing ‘Handcuffs’ To Pursue Pharma Companies, PBMs For Antitrust Violations

Agency staff has more freedom to launch investigations under resolutions approved at Commission’s first meeting under new chair. Mergers and rebate walls expected to be major priorities.

FTC building
FTC authorizes investigations of pharma companies and pharmacy benefit managers • Source: Alamy

More from Compliance

More from Pink Sheet